Mark Hamann to Drug Discovery
This is a "connection" page, showing publications Mark Hamann has written about Drug Discovery.
Connection Strength
1.528
-
Contemporary Approaches to the Discovery and Development of Broad-Spectrum Natural Product Prototypes for the Control of Coronaviruses. J Nat Prod. 2021 11 26; 84(11):3001-3007.
Score: 0.699
-
Advancement into the Arctic region for bioactive sponge secondary metabolites. Mar Drugs. 2011; 9(11):2423-2437.
Score: 0.351
-
Marine natural products in the discovery and development of potential pancreatic cancer therapeutics. Adv Cancer Res. 2019; 144:299-314.
Score: 0.148
-
Computationally Assisted Discovery and Assignment of a Highly Strained and PANC-1 Selective Alkaloid from Alaska's Deep Ocean. J Am Chem Soc. 2019 03 13; 141(10):4338-4344.
Score: 0.146
-
The first cyclomegastigmane rhododendroside A from Rhododendron brachycarpum alleviates HMGB1-induced sepsis. Biochim Biophys Acta. 2014 Jun; 1840(6):2042-9.
Score: 0.103
-
SB-224289 Antagonizes the Antifungal Mechanism of the Marine Depsipeptide Papuamide A. PLoS One. 2016; 11(5):e0154932.
Score: 0.030
-
Insights and ideas garnered from marine metabolites for development of dual-function acetylcholinesterase and amyloid-? aggregation inhibitors. Mar Drugs. 2014 Apr 04; 12(4):2114-31.
Score: 0.026
-
Asteropsins B-D, sponge-derived knottins with potential utility as a novel scaffold for oral peptide drugs. Biochim Biophys Acta. 2014 Mar; 1840(3):977-84.
Score: 0.025